Cytopathogenic Effect, Viral
"Cytopathogenic Effect, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.
| Descriptor ID |
D003588
|
| MeSH Number(s) |
E01.370.225.500.384.235 E05.200.500.384.235 E05.242.384.235 G06.920.190
|
| Concept/Terms |
Cytopathogenic Effect, Viral- Cytopathogenic Effect, Viral
- Cytopathic Effect, Viral
- Cytopathic Effects, Viral
- Effect, Viral Cytopathic
- Effects, Viral Cytopathic
- Viral Cytopathic Effect
- Viral Cytopathic Effects
- Viral Cytopathogenic Effect
- Cytopathogenic Effects, Viral
- Effect, Viral Cytopathogenic
- Effects, Viral Cytopathogenic
- Viral Cytopathogenic Effects
|
Below are MeSH descriptors whose meaning is more general than "Cytopathogenic Effect, Viral".
Below are MeSH descriptors whose meaning is more specific than "Cytopathogenic Effect, Viral".
This graph shows the total number of publications written about "Cytopathogenic Effect, Viral" by people in this website by year, and whether "Cytopathogenic Effect, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytopathogenic Effect, Viral" by people in Profiles.
-
Plesa G, McKenna PM, Schnell MJ, Eisenlohr LC. Immunogenicity of cytopathic and noncytopathic viral vectors. J Virol. 2006 Jul; 80(13):6259-66.
-
Brigandi LA, Lanfranchi PV, Scheiner ED, Busch SL. Herpes simplex virus infection presenting as a piriform sinus mass. Ear Nose Throat J. 2006 Jul; 85(7):450-1, 456.
-
Fang M, Sigal LJ. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J Immunol. 2005 Nov 15; 175(10):6829-36.
-
Schnell MJ, Buonocore L, Boritz E, Ghosh HP, Chernish R, Rose JK. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J. 1998 Aug 10; 17(5):1289-96.
-
Leon-Monzon ME, Illa I, Dalakas MC. Expression of poliovirus receptor in human spinal cord and muscle. Ann N Y Acad Sci. 1995 May 25; 753:48-57.
-
Reichard KW, Lorence RM, Katubig BB, Peeples ME, Reyes HM. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus. J Pediatr Surg. 1993 Oct; 28(10):1221-5; discussion 1225-6.
-
Ito M, Rodriguez-Bigas MA, Creaven PJ, Petrelli NJ. High prevalence of Inoue-Melnick virus antibodies in patients with colorectal carcinoma. Cancer Lett. 1992 Aug 31; 65(3):233-7.
-
Kaner RJ, Iozzo RV, Ziaie Z, Kefalides NA. Inhibition of proteoglycan synthesis in human endothelial cells after infection with herpes simplex virus type 1 in vitro. Am J Respir Cell Mol Biol. 1990 May; 2(5):423-31.
-
Abramczuk J, Vorbrodt A, Rubin DH, Fields BN, Koprowski H. Interactions of preimplantation mouse embryos with reovirus serotypes 1 and 3. Infect Immun. 1983 Oct; 42(1):301-7.
-
Friedman HM, Macarak EJ, MacGregor RR, Wolfe J, Kefalides NA. Virus infection of endothelial cells. J Infect Dis. 1981 Feb; 143(2):266-73.